Moderna, Inc. Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. for December 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.69 | 11,046 | 217,496 | 828,466 | 839.5 K to 828.5 K (-1.32 %) |
| Dec 16 2019 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 18.54 | 100,000 | 1,854,000 | 104,770 | 204.8 K to 104.8 K (-48.84 %) |
| Dec 16 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 18.53 | 11,046 | 204,682 | 839,512 | 850.6 K to 839.5 K (-1.30 %) |
| Dec 16 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 18.53 | 11,046 | 204,682 | 839,512 | 850.6 K to 839.5 K (-1.30 %) |
| Dec 16 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 18.53 | 11,046 | 204,682 | 839,512 | 850.6 K to 839.5 K (-1.30 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | J | 0.00 | 42,132 | 0 | 6,762,500 | 6.7 M to 6.8 M (+0.63 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | KANIA EDWIN M JR | 10% Owner | Sell | S | 18.81 | 100,000 | 1,880,840 | 498,847 | 598.8 K to 498.8 K (-16.70 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.65 | 38,366 | 715,710 | 8,190,766 | 8.2 M to 8.2 M (-0.47 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.65 | 199,935 | 3,729,747 | 31,216,399 | 31.4 M to 31.2 M (-0.64 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.96 | 4,092 | 77,579 | 8,229,132 | 8.2 M to 8.2 M (-0.05 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.96 | 21,325 | 404,292 | 31,416,334 | 31.4 M to 31.4 M (-0.07 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.99 | 27,714 | 526,408 | 8,233,224 | 8.3 M to 8.2 M (-0.34 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.99 | 144,423 | 2,743,199 | 31,437,659 | 31.6 M to 31.4 M (-0.46 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,735,720 | 0 | 0 | 1.7 M to 0 (-100.00 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,207,658 | 0 | 8,260,938 | 9.5 M to 8.3 M (-12.75 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 6,292,342 | 0 | 31,582,082 | 37.9 M to 31.6 M (-16.61 %) |
| Dec 11 2019 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 18.87 | 17,889 | 337,565 | 17,889 | |
| Dec 11 2019 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 18.87 | 39,720 | 749,516 | 39,720 | |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 0.00 | 229,358 | 0 | 0 | |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 0.00 | 229,357 | 0 | 0 | |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 20.93 | 1,306 | 27,335 | 1,362,510 | 1.4 M to 1.4 M (-0.10 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 20.39 | 147,528 | 3,008,096 | 1,363,816 | 1.5 M to 1.4 M (-9.76 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 19.34 | 89,698 | 1,734,759 | 1,511,344 | 1.6 M to 1.5 M (-5.60 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 20.64 | 229,358 | 4,733,949 | 1,601,042 | 1.4 M to 1.6 M (+16.72 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 20.64 | 229,357 | 4,733,928 | 1,371,684 | 1.1 M to 1.4 M (+20.08 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.95 | 200 | 4,190 | 850,558 | 850.8 K to 850.6 K (-0.02 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.43 | 6,200 | 126,666 | 850,758 | 857 K to 850.8 K (-0.72 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 19.42 | 4,646 | 90,225 | 856,958 | 861.6 K to 857 K (-0.54 %) |
| Dec 03 2019 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 20.54 | 11,046 | 226,885 | 861,604 | 872.7 K to 861.6 K (-1.27 %) |